Latest Knoll Capital Management, LP Stock Portfolio
Knoll Capital Management, LP Performance:
2025 Q2: -7.6%YTD: -7.21%2024: 6.81%
Performance for 2025 Q2 is -7.6%, and YTD is -7.21%, and 2024 is 6.81%.
About Knoll Capital Management, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Knoll Capital Management, LLC reported an equity portfolio of $140.7 Millions as of 30 Jun, 2025.
The top stock holdings of Knoll Capital Management, LLC are ALDX, , ENTX. The fund has invested 14.9% of it's portfolio in ALDEYRA THERAPEUTICS INC and 9% of portfolio in BIOHAVEN PHARMACTL HLDG CO L.
The fund managers got completely rid off EQUINOX GOLD CORP stocks. They significantly reduced their stock positions in SKEENA RES LTD CAD (SKE). Knoll Capital Management, LLC opened new stock positions in ABEONA THERAPEUTICS (ABEO) and CENTERRA GOLD INC. The fund showed a lot of confidence in some stocks as they added substantially to ALAMOS GOLD INC and ROYAL GOLD INC. (RGLD).
The top stock holdings of Knoll Capital Management, LLC are ALDX, , ENTX. The fund has invested 14.9% of it's portfolio in ALDEYRA THERAPEUTICS INC and 9% of portfolio in BIOHAVEN PHARMACTL HLDG CO L.
The fund managers got completely rid off EQUINOX GOLD CORP stocks. They significantly reduced their stock positions in SKEENA RES LTD CAD (SKE). Knoll Capital Management, LLC opened new stock positions in ABEONA THERAPEUTICS (ABEO) and CENTERRA GOLD INC. The fund showed a lot of confidence in some stocks as they added substantially to ALAMOS GOLD INC and ROYAL GOLD INC. (RGLD).
Knoll Capital Management, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Knoll Capital Management, LLC made a return of -7.6% in the last quarter. In trailing 12 months, it's portfolio return was -7.23%.
New Buys
| Ticker | $ Bought |
|---|---|
| abeona therapeutics | 356,073 |
| centerra gold inc | 170,300 |
| orchestra biomed holdings | 169,824 |
New stocks bought by Knoll Capital Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| alamos gold inc | 21.95 |
| royal gold inc. | 19.21 |
| biohaven pharmactl hldg co l | 7.75 |
Additions to existing portfolio by Knoll Capital Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| skeena res ltd cad | -6.34 |
Knoll Capital Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| equinox gold corp | -3,789,580 |
Knoll Capital Management, LP got rid off the above stocks
Sector Distribution
Knoll Capital Management, LLC has about 51.6% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 51.6 |
| Healthcare | 42.4 |
| Industrials | 1.7 |
| Basic Materials | 1.7 |
| Consumer Defensive | 1.3 |
| Financial Services | 1.2 |
Market Cap. Distribution
Knoll Capital Management, LLC has about 4.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 52.1 |
| SMALL-CAP | 17.8 |
| MICRO-CAP | 15.2 |
| NANO-CAP | 8.4 |
| LARGE-CAP | 3 |
| MID-CAP | 2.2 |
| MEGA-CAP | 1.2 |
Stocks belong to which Index?
About 31.1% of the stocks held by Knoll Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 68.9 |
| RUSSELL 2000 | 27.8 |
| S&P 500 | 3.3 |
Knoll Capital Management, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Knoll Capital Management, LP
Knoll Capital Management, LLC has 38 stocks in it's portfolio. About 66.1% of the portfolio is in top 10 stocks. ALDX proved to be the most loss making stock for the portfolio. ENTX was the most profitable stock for Knoll Capital Management, LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALDX | aldeyra therapeutics inc | 14.91 | 5,475,520 | 20,971,200 | unchanged | 0.00 | ||
Historical Trend of ALDEYRA THERAPEUTICS INC Position Held By Knoll Capital Management, LPWhat % of Portfolio is ALDX?:Number of ALDX shares held:Change in No. of Shares Held: | ||||||||
| biohaven pharmactl hldg co l | 8.98 | 895,269 | 12,632,200 | added | 7.75 | |||
| ENTX | entera bio ltd | 7.95 | 5,881,880 | 11,175,600 | unchanged | 0.00 | ||
| GLD | spdr gold trust | 6.93 | 32,000 | 9,754,560 | unchanged | 0.00 | ||
| MGTX | meiragtx holdings | 5.79 | 1,250,000 | 8,150,000 | unchanged | 0.00 | ||
| kinross gold corp | 4.89 | 440,000 | 6,877,200 | unchanged | 0.00 | |||
| agnico eagle mines ltd | 4.69 | 55,500 | 6,600,620 | unchanged | 0.00 | |||
| sandstorm gold ltd | 4.68 | 700,000 | 6,580,000 | unchanged | 0.00 | |||
| AVDL | avadel pharmaceuticals plc | 3.78 | 600,000 | 5,310,000 | unchanged | 0.00 | ||
| elicio therapeutics inc | 3.46 | 630,915 | 4,870,660 | unchanged | 0.00 | |||
| SKE | skeena res ltd cad | 3.34 | 295,400 | 4,702,770 | reduced | -6.34 | ||
| seabridge gold inc | 3.27 | 317,003 | 4,602,880 | unchanged | 0.00 | |||
| ALT | altimmune inc | 3.09 | 1,121,520 | 4,340,300 | unchanged | 0.00 | ||
| franco nev corp | 2.91 | 25,000 | 4,098,000 | unchanged | 0.00 | |||
| mag silver corp | 2.55 | 170,000 | 3,592,100 | unchanged | 0.00 | |||
| NUVB | nuvation bio inc | 2.08 | 1,025,000 | 2,922,250 | unchanged | 0.00 | ||
| SLV | ishares silver trust | 1.87 | 80,000 | 2,624,800 | unchanged | 0.00 | ||
| APLT | applied therapeutics inc | 1.73 | 7,799,690 | 2,425,700 | unchanged | 0.00 | ||
| OCUL | ocular therapeutix inc. | 1.32 | 600,400 | 1,859,710 | unchanged | 0.00 | ||
| PM | philip morris intl. inc | 1.29 | 10,000 | 1,821,300 | unchanged | 0.00 | ||
